Task: Answer the MCQ question.
Query: Which drug exhibits a 3.330% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
[a] COCCSc1nnc(NC(=O)C2CC(=O)N(CCc3ccc(F)cc3)C2)s1
[b] O=C(NCc1ccccc1Cl)c1ccc[nH]1
[c] COc1ccc(OC)c(NC(=O)Nc2ccc(Cl)cc2)c1
Answer: a. COCCSc1nnc(NC(=O)C2CC(=O)N(CCc3ccc(F)cc3)C2)s1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COCCSc1nnc(NC(=O)C2CC(=O)N(CCc3ccc(F)cc3)C2)s1
COCCSc1nnc(NC(=O)C2CC(=O)N(CCc3ccc(F)cc3)C2)s1
1-[2-(4-fluorophenyl)ethyl]-N-[5-(2-methoxyethylsulfanyl)-1,3,4-thiadiazol-2-yl]-5-oxopyrrolidine-3-carboxamide